2023 ACMT Annual Scientific Meeting - On-Demand
- Non-member - Tier I - $500
- Non-member - Tier II - $300
- Non-member - Tier III - $250
- Non-member - Tier IV - $225
- Member - Tier I - $375
- Member - Tier II - $260
- Member - Tier III - $225
- Member - Tier IV - $200
The ACMT Annual Scientific Meeting (ASM) provides various lectures and panels on a variety of cutting-edge topics, giving specialists in the field of medical toxicology to learn from the research of their peers.
This on-demand material consists of recordings and posters from all three days of the 2023 Annual Scientific Meeting that was held in San Diego on March 31-April 2, 2023.
The PFAS Epidemic: Addressing The Challenge
ASAM Collaborative Panel: Pain and Perioperative Management in Patients with Opioid Use Disorder
Annual Review of Medical Toxicology Publications - Articles You May Have Missed from 2022-2023
MedTox and Modern Warfare: Radiation and Current Events
AACT Collaborative Panel: Mother, Baby and MOUD
International Sessions by APAMT, EAPCCT & MENATOX
A Brief History of Pharmaceutical Compounding and the Errors Associated with It
Novel Treatments in the Pipeline for Envenomations
Making Social Media Nontoxic to Toxicologists
What You Need to Know About MyToxCert and Recertifying in Medical Toxicology
NOTE: Continuing Education is NOT available for this enduring, on-demand material.
If you are interested in purchasing access to the on-demand ACMT Suicidality Symposium that preceded the meeting, check out the link below!
#ACMT2023 In-Person Attendees: access to this on-demand course was included in the original registration fee for the in-person event. If you attended the in-person conference in San Diego (March 31-April 2, 2023) you should automatically be given access. If you have not received this automatic access, please write to us at: firstname.lastname@example.org.
Member Tier I: Full, Affiliate, International, Emeritus
| Member Tier II: Fellows|
Member Tier III: Residents, International - Developing Country
| Member IV: Medical Students|
Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other"
|Non-member Tier II: Fellows, SPIs, Nurses, etc.|
Non-member Tier III: Educators & Emergency Responders
| Non-member IV: Residents & Students|
- 90-day access to the course from date of purchase
- Access to plenary recordings, lecture slides, and posters from all three days of the 2023 ACMT Annual Scientific Meeting in San Diego, CA.
- Downloadable Certificate of Completion
Interested in becoming an ACMT Member? Contact our Membership Manager, Jenn Dorsey, at email@example.com. Learn more at: www.acmt.net/membership
There is no Continuing Education available for this on-demand enduring material.
Refunds and Cancellations
For questions regarding our refund and cancellation policy, please email us at firstname.lastname@example.org.
Once you have completed your registration:
- Click on the Contents tab. This is where you will be able to see the recordings from this event.
- Access the slides and posters in the Slides tab. You will be able to download and review all the speaker slides.
- Download Certificate of Completion. This certificate is not a record for Continuing Education, this is a record of your completion of this on-demand, enduring activity. You will be able to download the certificate until your course registrations expires.
Need Assistance or Have Questions?
For assistance logging in, accessing content, or for other questions, please contact us at email@example.com or visit our FAQ page.
If you are in need of accessible learning accommodations, please contact firstname.lastname@example.org for additional assistance.
2023 Annual Scientific Meeting - Day 1
Platform Session 1 | 59 min
The platform session features talks from Dr. David Juurlink from Sunnybrook Health Sciences Centre; Anna Gerald from Mercer University School of Medicine; Dr. Rachel Culbreth, ToxIC Medical Director; and Dr. Hannah St. Francis from the New York University School of Medicine. Dr. Juurlink reexamines a case of neonatal death ostensibly caused by opioids passed via breast milk. Anna Gerald investigates the potential relationship between exposure to endocrine-disrupting lead and serum estrogen levels in adult women. Dr. Culbreth discusses the pediatric risk of mortality-III and pediatric index of mortality scores among pediatric poisonings, and Dr. St. Francis examines the comparison of RADARS® Web Monitoring and NPDS data.
Donovan Lectureship | Gut-Brain Axis and Psychoneuroendocrinology: Translation to Addiction Medicine | 46 min
Dr. Lorenzo Leggio, Branch Chief & Acting Clinical Director of NIDA at the National Institutes of Health, identifies increasing knowledge in regard to medication development efforts in the addiction field.
This lectureship was supported by the Medical Toxicology Foundation through the Ward and Ryan Donovan Memorial Fund. For more info, please visit: www.acmt.net/donovan-lectureship
The PFAS Epidemic: Addressing The Challenge | 40 min
Director & PI of the Region 1 New England Pediatric Environmental Health Specialty Unit, Dr. Alan Woolf describes the potential health effects of PFAs. He also discusses strategies for patient management and identifies resources available to clinical toxicologists.
X-Factor: Xylazine | 59 min
The panel features talks from Dr. Matthew Salzman, Assistant Professor at Cooper Medical School of Rowan University; Dr. Michael Levine, Associate Professor and Director of Toxicology at the University of California; and Dr. Josh Debord, Senior Scientist at the Center for Forensic Science Research and Education. Dr. Salzman discusses the potential pathophysiology of xylazine-associated soft-tissue infections and also the potential pathophysiology of xylazine withdrawal and its management. Dr. Levine discusses opioid overdoses that involve xylazine, and Dr. Debord details the purpose and design of CFSRE projects involving xylazine.
ASAM Panel | Tricks of the Trade: Pain and Perioperative Management in Patients with OUD | 61 min
This panel discusses the protocol for buprenorphine and strategies for treating pain for patients taking it. The speakers for this panel are: Katherine Katzung, MD, FASAM; JoAn Laes, MD, FACMT, FASAM; and Timothy Wiegand, MD, FACMT, FAACT, DFASAM (moderator).
This was session was developed in collaboration with the American Society of Addiction Medicine (ASAM).
Annual Review of Medical Toxicology Publications - Articles You May Have Missed from 2022-2023 | 25 min
Dr. Dan McCabe, Director of the Division of Medical Toxicology at the University of Iowa Carver College of Medicine and Associate Medical Director of the Iowa Poison Control Center, reviews a selection of articles relevant to medical toxicologists.
2023 Annual Scientific Meeting - Day 2
Platform Session 2 | 56 min
The platform session features four talks from Dr. Andrew Piner, University of Maryland School of Medicine; Dr. Frank Dicker, Washington University School of Medicine; Dr. Rita Farah; and Dr. Craig Smollin. Dr. Piner examines the utilization of VV-ECMO in acute poisoning, and Dr. Dicker analyzes the number and variety of substances within a regional sample of the illicit drug supply. Dr. Farah examines the trends in medical outcomes of human exposures reported to poison centers. Dr Smollin discusses the California Substance Use Line.
MedTox and Modern Warfare: Radiation and Current Events | 32 min
Dr. Ziad Kazzi, Professor of the Department of Emergency Medicine at Emory University, discusses the intersection between medical toxicology and modern warfare with a particular focus on radiation and current Events.
ACMT Career Achievement Award | B is for Botulism | 45 min
Dr. B. Zane Horowitz, Associate Medical Director of Oregon-Alaska-Guam Poison Centers and Medical Director of Utah Poison Control Center, delivers the 2023 ACMT Career Achievement Address.
AACT Panel | Mother, Baby & MOUD | 59 min
The panel, which consists of Dr. Meghan Spyres, Clinical Associate Professor of Emergency Medicine, Banner – University Medical Center Phoenix, and Dr. Joshua D. Trebach, Emergency Medical Physican and Medical Toxicologist at the University of Iowa Hospitals and Clinics, discusses the growing problem of micro solutions in regards to pregnancy and MOUD.
This session was developed in collaboration with the American Academy of Clinical Toxicology (AACT).
MedTox Case Panel: Case-Based Conundrums | 89 min
The panel discusses a variety of cases. Dr. Arthur Daigh, a fellow at Indiana University/Indiana Poison Center, presents a case involving saw scale viper envenomation treated with Inoserp© MENA. Dr. Betty Shuk Chan's, an attending at Prince of Wales Hospital, case involves recurrent and escalating salicylate poisoning, and Dr. Ryan Cole, a fellow at the University of Virginia, examines complications of naloxone administration and inappropriate early code status changes.
MedTox Shark Tank Research Forum | 89 min
Five Medical Toxicology fellows present research presentations to a panel:
- Gastrointestinal Sequestration of Lipid Soluble Toxins, Noah Berland, MD, Fellow - 2nd Year, Rutgers New Jersey Medical School Medical Toxicology Fellowship, Newark, NJ
- Does Knowledge Inspire Action?, Juliana Chang, MD, Fellow - 2nd Year, Northwell Health Medical Toxicology, Manhasset, NY
- Identification of Barriers to Placement in IPV Shelters for Individuals with Substance Use Disorders, Tori Erhardt, MD, Medical Resident, Emory University School of Medicine, Atlanta, GA
- Climate Trends In US Incidence of Algal Toxin and Algal Toxin Associated Exposures, Brett Johnson, MD, Fellow - 1st Year, UMass Memorial Toxicology Fellowship, Worcester, MA
- Pharmacogenomic Investigation of Cannabis Hyperemesis Syndrome and Cannabis Use Disorder, Jennifer Zacharia, MD, Fellow - 1st Year, UMass Memorial Toxicology Fellowship, Worcester, MA
Travel awards for this activity were made possible through the sponsorship of Johnson and Johnson Consumer Health.
Open Mic Competition | 89 min
The competition features six short talks on a variety of topics by Medical Toxicology fellows:
- Which to Lick? Take Your Pick, Alexia Armenta, MD, 1st YR Fellow, Toxikon Consortium
- How Sweet It Is (to be cared by you), Juliana Chang, MD, 2nd YR Fellow, Northwell Health Medical Toxicology
- From Fang to Needle: Venom Throughout History, Samy Chettat, MD, 1st YR Fellow, Oregon Health and Sciences University
- The Sensitive Artist, Matthew Dernbach, MD, Medical Resident, Medical University of South Carolina
- Aum Shinrikyo – the cult of toxicologic terrorism, Michael Kennan, MD, 2nd YR Fellow, SUNY Upstate Medical University
- Bring Back the Barb, Christopher Mitchell, MD, 1st YR Fellow, Einstein Healthcare Network
- Pruno: A Recipe for Paralysis, Tuyet-Anh Nguyen, MD, 2nd YR Fellow, Rutgers University
- Reframing Toxicology: A “Disease” of Socioeconomic Disparities, Josue Zozaya, MD, Medical Residnt, UTSW Emergency Medicine
2023 Annual Scientific Meeting - Day 3
Lightning Oral Session | 60 min
The session consists of multiple, 5-minute presentations on a range of relevant topics. Speakers include: Dr. David Schaffer, University of Virginia; Dr. Paul Wax, Executive Director of the American College of Medical Toxicology; Dr. Madeline Renny, Icahn School of Medicine at Mount Sinai; Dr. Brandtly Yakey, Michigan Poison and Drug Information Center at Wayne State University School of Medicine; Dr. Daniel Lasoff, Department of Emergency Medicine at UC San Diego; and Dr. Anne-Michelle Ruha, Banner - University Medical Center.
International Panel | APAMT, EAPCCT & MENATOX | 60 min
Representatives from APAMT, EAPCCT, and MENATOX deliver three talks on relevant toxicological issues from around the world. Dr. Nasim Zamani, Fellowship of Clinical Toxicology at Shahid Beheshti University, discusses aluminum phosphide poisoning signs, symptoms, and treatments. Dr. Ophir Lavon, Head of the Clinical Pharmacology and Toxicology Unit at Carmel Medical Center, discusses tetrodotoxin poisoning and Lessepsian migration to the Mediterranean Sea, and Dr. Tharwat El Zahran, Assistant Professor of Emergency Medicine and Co-director of Toxicology Service at the American University of Beirut Medical Center, discusses the Ammonium nitrate blast and the environmental implications in Lebanon.
This session was developed in collaboration with the Asia Pacific Association of Medical Toxicology (APAMT), European Association of Poisons Centres and Clinical Toxicologists (EAPCCT), and the Middle East & North Africa Clinical Toxicology Association (MENATOX).
Professional Development Workshop 1: A Toxicologist Loose in Med School, Opportunities for Undergraduate Medical Education | 25 min
Drs. Matthew Zuckerman, Associate Professor at the University of Colorado School of Medicine; Jeffrey Suchard, Professor of Clinical Emergency Medicine and Associate Dean for Basic Science Education at the University of California, Irvine; and Brenna Michelle Farmer, Vice Chief of Clinical Services at the NYP Brooklyn Methodist Hospital, identify reasons and opportunities to participate in undergraduate medical education. They also discuss the current framework of UME and opportunities to engage with and support that framework.
Professional Development Workshop 2: Supplementing Tox Fellowship Training to Enhance the Practice of Addiction Medicine | 29 min
Dr. Leslie R. Dye, Clinical Professor of Emergency Medicine and Assistant Medical Director at Wright State University/Boonshoft School of Medicine, gives a presentation on supplementing a medical toxicology fellowship with addiction medicine.
A Brief History of Pharmaceutical Compounding and the Errors Associated with It | 32 min
Drs. Christopher James Watson, Emergency Medicine Attending Physician at Beth Israel Deaconess Medical Center, and James Whitledge, Medical Toxicology Fellow at Boston Children's Hospital, describe pharmaceutical compounding, including its purpose, history, and regulation in the United States along with possible errors via a 30-year systematic review.
Novel Treatments in the Pipeline for Envenomations | 26 min
Assistant Clinical Professor at Toxicology Associates, Dr. Nicklaus Brandehoff examines new and novel treatments for envenomations that are in development.
Making Social Media Nontoxic to Toxicologists | 32 min
Drs. Joshua Trebach, Emergency Medical Physician and Medical Toxicologist at the University of Iowa Hospitals and Clinics, and Ryan Marino, Assistant Professor at the University Hospitals Cleveland & Case Western Reserve University School of Medicine, discuss addressing medical misinformation and utilizing social media for tox education.
What You Need to Know About MyToxCert and Recertifying in Medical Toxicology | 29 min
Drs. Andrew Stolbach, Medical Toxicologist and Emergency Physician at Johns Hopkins University, and Robert Hendrickson, Director of Emergency Medicine at Oregon Health & Science University, provide MedTox Continuing Certification updates and review MyToxCert elements.
Nicklaus Brandehoff, MD
Assistant Clinical Professor
Dr. Brandehoff is board certified in emergency medicine, medical toxicology, and addiction medicine with a focus on envenomation research. He has an appointment as Assistant Clinical Professor of Emergency Medicine at the University of Colorado School of Medicine and is faculty at the Rocky Mountain Poison and Drug Center. He is also the President and Medical Director for the Asclepius Snakebite Foundation, a 501(c)3 non-profit, that focuses on improving snakebite education and management in West Africa.
Joshua DeBord, PhD
The Center for Forensic Science Research and Education
Dr. Joshua (Josh) DeBord is a Senior Scientist at the CFSRE working in the areas of forensic toxicology and forensic chemistry. Dr. DeBord joined the CFSRE in early 2022 and performs R&D on challenging toxicological casework and profiles physical drug evidence on projects related to the CFSRE’s drug characterization initiatives, including CFSRE’s NPS Discovery program.
Dr. DeBord graduated with a B.S., M.S., and Ph.D., each in Chemistry, from Florida International University (FIU) in Miami, FL. Dr. DeBord’s doctoral research was conducted under the mentorship of Professor José Almirall on profiling and geographic provenance determination of heroin. Before joining CFSRE, Dr. DeBord was employed at the North Louisiana Crime Lab in Shreveport, LA, as a forensic chemist and toxicologist. Beginning there in 2018, Dr. DeBord and two colleagues started the toxicology section from only blood ethanol analysis to ISO/IEC 17025:2017 accreditation for qualitative determination and quantitative measurement of most drugs by March 2020. He also assisted with the development and implementation of the North Louisiana Crime Lab’s statistical sampling procedure to reduce backlog in the large-seizure drug casework. He continued to perform casework analysis and expert testimony before joining CFSRE in 2022.
Dr. DeBord is passionate about teaching, research, and mentorship. His research interests focus on applied research for increasing the capabilities of publicly funded forensic labs and improving the work experience for forensic professionals.
Leslie R. Dye, MD, FACMT, FASAM, FACCT
Clinical Professor, Emergency Medicine, Assistant Medical Director
Wright State University/Boonshoft School of Medicine, OneFifteen
Leslie R. Dye, MD is triple board certified in emergency medicine, medical toxicology, and addiction medicine. She has worked in the fields of medical toxicology and addiction medicine for 30 years. In addition to her clinical expertise, she has academic and business content expertise from experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal (Journal of Medical Toxicology) and EIC of physician and pharmacist content production for a leading international medical digital content provider. Her deep subject matter expertise is demonstrated in her role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer reviewed publications and 16 textbook chapters, 66 national and 11 international presentations, 10 various commentaries, interviews, and podcasts. Her leadership skills have been proven in both corporate and academic environments, as professor at a medical school, long-term board member and past president of the American College of Medical Toxicology, Chair of the Addiction Medicine Committee, former co-chair, and co-moderator of the AACT Acute and Intensive Care Symposium, and as the manager of as many as 30 team members at an international corporation. She received a funded grant that enabled her to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over 3 years in the US. Dr. Dye is experienced in and continues to provide medical care in remote polar regions with no access to advanced medical facilities.
Tharwat El Zahran, MD
Medical Director, Assistant Professor of Emergency Medicine
American University of Beirut Medical Center
Dr. Tharwat El Zahran is an Assistant Professor of Emergency Medicine and the Medical director for the emergency department at the American University of Beirut Medical Center (AUBMC)
She completed a fellowship training in medical toxicology at Emory University and CDC, and currently co-directs the medical toxicology service at AUBMC.
Brenna Farmer, MD, MBA, MS
Vice Chair & Chief of Emergency Medicine
NYP Brooklyn Methodist Hospital & Weill Cornell Medicine Department of Emergency Medicine
Dr. Brenna Farmer is Chief of Emergency Medicine at NY Presbyterian Brooklyn Methodist Hospital and Vice Chair in the Department of Emergency Medicine at Weill Cornell Medicine's Department of Emergency Medicine. She trained in Emergency Medicine at Vanderbilt University Medical Center and in toxicology at NYU/Bellevue and the New York City Poison Control Center. She earned her medical degree from East Carolina University's Brody School of Medicine and her executive MBA from Cornell and MS in Healthcare Leadership from Cornell's Weill Cornell Graduate School of Medical Sciences. Her major academic interests are medication safety, patient safety, and acute bedside care of the toxicologic patient.
Rob Hendrickson, MD
Professor of Emergency Medicine, Medical Director, Program Director
Oregon Health and Science University, Oregon Poison Center, OHSU Fellowship in Medical Toxicology
Dr. Hendrickson is a Professor of Emergency Medicine and Medical Toxicologist at the Oregon Health and Science University (OHSU) in Portland, Oregon. He is the Program Director of the Fellowship in Medical Toxicology at OHSU and the Medical Director of the Oregon Poison Center, serving Oregon, Alaska, and Guam.
B. Zane Horowitz, MD, FACMT
Associate Medical Director
Oregon-Alaska-Guam Poison Centers
Dr. B. Zane Horowitz served as the medical director of the Oregon-Alaska-Guam Poison Center for 22 years. He also served as the medical director for the Utah Poison Control Center for 7 of those years. He currently continues to teach at Oregon Health and Science University in medical toxicology, and has authored over 90 publications.
Katherine Katzung, MD, FACEP, FASAM
Director of Addiction & Toxicology Program & Emergency Care Physician
Abbott Northwestern Hospital & Emergency Care Consultants
Katherine Katzung, MD is an attending physician in the emergency department at Abbott Northwestern, where she serves as chair of the department. Additionally, she is the medical director of the hospital’s addiction medicine and toxicology program, which began in 2020 after she received grant funding to initiate a hospital-based toxicology/addiction medicine consult service as well as an emergency department-based addiction medicine "bridge" clinic to provide continuity of care for patients initiated on Suboxone. This innovative program allows patients evaluated at Abbott Northwestern in the emergency department or inpatient units continuity of care, while focusing on harm-reduction strategies, until they can be given a warm hand-off to community providers.
A graduate of the University of Minnesota School of Medicine, she completed emergency medicine training at Regions Hospital in St. Paul and additional fellowship training in medical toxicology. She is board certified in emergency medicine, medical toxicology, and addiction medicine. Her clinical interests surround the intersection of these 3 specialties, with special focus on early ED & hospital-based interventions to evaluate and treat substance use disorder, including initiation of medication assisted therapies.
She volunteers as a consultant for the Minnesota Poison Control System in addition to serving on the board of the Steve Rummler HOPE Network and acts as medical director of its overdose prevention program.
Ziad Kazzi, MD, FAAEM, FACEP, FACMT, FAACT
Professor, Department of Emergency Medicine
Emory University School of Medicine
Born in 1975 and raised in Beirut, Lebanon, Dr. Kazzi trained in Emergency Medicine at Emory University in Atlanta (2000-03) where he served as a chief resident before completing a subspecialty fellowship in Medical Toxicology at Emory University, Georgia Poison Center and the Centers for Disease Control and Prevention (CDC) in Atlanta. He is board certified in both Emergency Medicine and Medical Toxicology. Dr. Kazzi joined the Department of Emergency Medicine at the University of Alabama at Birmingham (UAB) between 2005 and 2008 where he served as a Medical Toxicologist for the Regional Poison Control Center in Birmingham and the Alabama Poison Center. Currently, he is an associate professor at the department of Emergency Medicine at Emory University in Atlanta, Georgia as well as the director of the International Toxicology Postdoctoral Fellowship Program at Emory University (http://www.em.emory.edu/services/toxicology/international_postdoc_training.html).
He is also the assistant medical director of the Georgia Poison Center (www.georgiapoisoncenter.org) and a medical toxicologist at the Radiation Studies Branch of the National Center for Environmental Health at the CDC (https://www.cdc.gov/nceh/radiation/) where he participates in emergency preparedness and response activities in radiation.
As an emergency physician and toxicologist, Dr. Kazzi specializes in the recognition, triage, and management of poisonings and holds a deep interest in the areas of Radiation and International Toxicology. Over the past decade, he developed strong ties to India in the areas of medical toxicology, mass gathering medical preparedness, radiation emergency medicine, blast injuries and hazmat. Through his collaboration with the CDC, AIIMS, and PGIMER Chandigarh, he has delivered and co-directed the first Advanced Hazmat Life Support trainings in Ahmedabad and Delhi. He organized a number of training conferences in Nashik, Pune, Ujjain and Delhi and has been an invited speaker at the annual INDUS EM world congress. He is an active and founding board member of the Middle East North Africa Toxicology Association (www.menatox.org) and currently serves as its President. He is also a board member and chairs the International Committee of the American College of Medical Toxicology (www.acmt.net).
JoAn Laes, MD, DFASAM, FACMT
Addiction Staff Physician
Abbott Northwestern Hospital, Allina Health
JoAn Laes, MD, DFASAM, FACMT is an addiction medicine physician in Minneapolis, Minnesota, focusing on inpatient addiction medicine and toxicology consultation as well as experience in outpatient treatment of opioid and other substance use disorders. She is also a core medical toxicology faculty for the Minnesota Poison Center, Minneapolis, Minnesota, and medical director for Missions Inc. Detox facility in Plymouth, Minnesota. She is board certified in Internal Medicine, Medical Toxicology, and Addiction Medicine. She completed internal medicine residency at Hennepin County Medical Center and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota.
Ophir Lavon, MD, FEAPCCT
Head, Clinical Pharmacology and Toxicology Unit & Chair
Carmel Medical Center & Israel Society of Toxicology
Ophir Lavon is a Doctor of Medicine (MD) at the Rappaport Faculty of Medicine, Technion–Israel Institute of Technology. He is a Board-Certified Expert in Internal Medicine, Clinical Pharmacology and Toxicology. Dr. Lavon is the current chair of the Israel Society of Toxicology. He is a Fellow and a board member of the European Association of Poisons Centres and Clinical Toxicologists. He is heading the Clinical Pharmacology and Toxicology Unit, Carmel Medical Center in Haifa, Israel. Dr. Lavon is a Clinical Senior Lecturer at the Rappaport Faculty of Medicine. He also serves as the Chair of the National Antidote Stockpiling Committee. He is a board member of the Israel Association for Clinical Pharmacology, and a member of the American College of Medical Toxicology. He is the Former Head of the Patient Safety and Risk Management Unit, Carmel Medical Center in Haifa, Israel.
Lorenzo Leggio, MD, PhD
Branch Chief & Acting Clinical Director
NIDA & NIAAA
Dr. Lorenzo Leggio is a Senior Investigator in the NIH Intramural Research Program (IRP) with faculty appointments both at NIDA and NIAAA. He serves as Chief of the Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, a joint NIDA and NIAAA laboratory. He also serves as the NIDA Deputy Scientific Director, NIDA Acting Clinical Director, and Chief of the NIDA IRP Translational Addiction Medicine Branch. He also serves as a NIH Senior Attending Medical Staff and as senior medical advisor to the NIAAA Director. Dr. Leggio received his M.D. and Ph.D. from the Catholic University of Rome and ‘Agostino Gemelli’ hospital, where he also completed residency and received Board Certification in Internal Medicine. He was a visiting research associate, then postdoctoral research associate in Psychiatry and Human Behavior at Brown University, Providence, RI. In 2010, he joined the faculty of the Brown University Medical School as Assistant Professor at the Brown University Center for Alcohol and Addiction Studies, where he still holds an adjunct appointment as Professor in Behavioral and Social Sciences. He is also an Adjunct Professor of Addiction Medicine at Johns Hopkins University and Adjunct Professor of Neuroscience at Georgetown University.
Dr. Leggio’s clinical research has been primarily focused on the treatment of alcohol and substance use disorders, with a special emphasis on the role of microbiome-gut-liver-brain and neuroendocrine pathways as well as GABAergic pathways; and on the medical consequences of alcohol use disorder, focusing on alcohol-associated liver disease. As a Principal Investigator at Brown University, Dr. Leggio received extramural research funding from NIAAA and NIDA, as well as from Brown University, the European Foundation for Alcohol Research, ABMRF/The Foundation for Alcohol Research, and the Brain and Behavior Research Foundation (NARSAD Young Investigator Award). At Brown University first, and at the NIH since 2012, Dr. Leggio, together with his team, colleagues and collaborators have pioneered and conducted work on medication development, on the role of the microbiome-gut-liver-brain axis and on the role of neuroendocrine pathways in addictive behaviors via human laboratory studies and clinical trials as well as via translational and reverse translational experimental medicine approaches.
In 2022, Dr. Leggio was elected Fellow of the American College on Neuropsychopharmacology. Among other awards, Dr. Leggio received the 2008 Nordmann Award from the European Society for Biomedical Research on Alcoholism, the 2016 Early Career Investigator Award from the Research Society on Alcoholism, the 2018 Eva King Killam Award from the American College on Neuropsychopharmacology and the 2020 Jacob P. Waletzky Award from the Society for Neuroscience.
Michael Levine, MD, FACMT
Associate Professor of Emergency Medicine
University of California, Los Angeles
Michael Levine is a Los Angeles native, who completed his emergency medicine residency at the Harvard Affiliated Emergency Medicine program, based out of Brigham and Women’s Hospital and Massachusetts General Hospital. After residency, he completed his medical toxicology fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ. After staying as faculty for a year in Phoenix, he moved back to Los Angeles, where he joined the faculty at USC. He is currently the division chief of medical toxicology. He is actively involved in patient care, research, and serves on numerous hospital and university committees. He is an active member of American College of Emergency Physicians, the American College of Medical Toxicology, and is a member of the Toxicology Investigator's Consortium.
Ryan Marino, MD
Assistant Professor, Departments of Emergency Medicine & Psychiatry
Case Western Reserve University School of Medicine
Ryan Marino, MD is a medical toxicologist, emergency physician and addiction medicine specialist in Cleveland, OH. He currently practices at University Hospitals Cleveland Medical Center, Cincinnati Children’s Hospital Drug and Poison Information Center, and is an Assistant Professor in the Departments of Emergency Medicine and Psychiatry at Case Western Reserve University School of Medicine. He is the Medical Director for the Toxicology & Addiction Bridge Clinic at University Hospitals Cleveland Medical Center. Outside of work he can often be found spending way too much time on social media.
Dan McCabe, MD
Director of the Division of Medical Toxicology & Associate Medical Director
University of Iowa & Iowa Poison Control Center
Dr. Dan McCabe is a medical toxicologist and emergency medicine physician at the University of Iowa Hospitals & Clinics, as well as a Clinical Assistant Professor of Emergency Medicine at the University of Iowa, the Director of the Division of Medical Toxicology at the University of Iowa, and the Associate Medical Director for the Iowa Poison Control Center. Dr. McCabe received his medical degree from the University of Iowa. He completed a residency in emergency medicine at Cook County Hospital and a fellowship in medical toxicology at the Regions Hospital/Minnesota Poison Control System. Dr. McCabe has a broad range of interests including improvement of care for the poisoned patient, toxicology, addiction medicine, resource utilization, and public health.
Matthew Salzman, MD
Cooper Medical School of Rowan University
Matthew Salzman received his Bachelor of Arts in Music from the University of Rochester and his Medical Degree from the Sidney Kimmel Medical College at Thomas Jefferson University. He trained in Emergency Medicine and Medical Toxicology at Drexel University College of Medicine. Currently, he is an Assistant Professor of Emergency Medicine in the Division of Medical Toxicology and Addiction Medicine at Cooper Medical School of Rowan University. He is the Medical Director for the In-patient Addiction Medicine Consult service as well as Medical Director for Research for Addiction Medicine at Cooper. He is also a volunteer consultant in toxicology for the Children's Hospital of Philadelphia and the Philadelphia Poison Control Center.
Meghan Spyres, MD, FACMT
Clinical Associate Professor of Emergency Medicine
Banner – University Medical Center Phoenix
Dr. Spyres received her MD from Columbia University College of Physicians and Surgeons in New York City and stayed in New York to complete an Emergency Medicine residency at Bellevue/New York University. She completed her Medical Toxicology fellowship training in 2016 at Banner—University Medical Center in Phoenix, Arizona. She is currently Associate Professor of Clinical Emergency Medicine at the University of Arizona College of Medicine Phoenix and faculty in the department of Medical Toxicology at Banner—University Medical Center Phoenix. Her research interests include envenomations, emerging drugs of abuse, gender in medicine, and the intersection of critical care and toxicology. She is co-founder of Women in Toxicology, a subgroup of ACMT that promotes women in academic medicine. Additionally, she is part the leadership team for ACMT’s Toxicology Investigators Consortium Registry (ToxIC), focusing on detecting trends in novel drugs of abuse.
Jeffrey Suchard, MD
Professor of Clinical Emergency Medicine & Associate Dean for Basic Science Education
University of California, Irvine
Jeffrey Suchard is an Emergency Physician and Medical Toxicologist at the University of California, Irvine. After undergraduate studies in Biochemistry at UC Berkeley, he attended medical school at UCLA, EM residency at UConn, then completed medical toxicology fellowship in Phoenix, AZ. Dr. Suchard has worked clinically at UC Irvine since 1999 and began his current involvement in medical student education in 2010. He teaches Epidemiology & Biostatistics to the MS1 class (since 2010), is the course director for MS2 Medical Pharmacology (since 2011), and serves as Associate Dean for Basic Science Education (since 2014).
Andrew Stolbach, MD, MPH
Medical Toxicologist and Emergency Physician
Johns Hopkins University
Andrew Stolbach is currently Chair of the American Board of Emergency Medicine (ABEM) Medical Toxicology Subboard. ABEM writes and administers board certification materials including MyToxCert.
Joshua Trebach, MD
Emergency Medicine Physician & Medical Toxicologist
University of Iowa Hospitals and Clinics
Josh Trebach is an emergency medicine physician and medical toxicologist at the University of Iowa Hospital and Clinics. He completed his undergraduate training at Virginia Tech, medical school training and residency at Johns Hopkins, and toxicology fellowship at New York University/New York City Poison Control Center. Josh is currently the Director of Resident Medical Toxicology Education at the University of Iowa and is passionate about all things toxicology, medical education, social media, LGBTQ health, and animal rescue.
Christopher James Watson, MD
Maine Medical Center
James Watson is a board certified medical toxicologist and emergency medicine physician practicing at Maine Medical Center and the Northern New England Poison Center, and is an Assistant Professor in the Department of Emergency Medicine at Tufts University School of Medicine. James graduated from the University of Chicago Pritzker School of Medicine in 2017 before completing residency training at the Harvard Affiliated Emergency Medicine Residency at Beth Israel Deaconess Medical Center and fellowship training at the Harvard Medical Toxicology Program at Boston Children’s Hospital; both in Boston, Massachusetts. His academic interests include medical education, resource utilization within medical toxicology, and critical care toxicology. James is a Portland native, and lives in Southern Maine with his wife, son, and rescue dog Mowgli.
James Whitledge, MD
Medical Toxicology Fellow
Boston Children's Hospital
James Whitledge, MD is a Medical Toxicology Fellow at Boston Children's Hospital in Boston, MA. He is also an Emergency Physician at Beth Israel Deaconess Medical Center Boston, MA. In his free time he also is the current Co-Chair of the AACT Herbs & Dietary Supplements Section.
Timothy Wiegand, MD, DFASAM, FACMT, FAACT
Director of Addiction Medicine and Addiction Medicine Consults
University of Rochester Medical Center
Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center in Rochester New York. He is Board Certified in Medical Toxicology and Addiction Medicine and practices in Addiction Toxicology with a mix of clinical, research, teaching, and other professional work. Dr. Wiegand has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and he is currently serving on the Board of Directors for the American Society of Addiction Medicine (ASAM) completing a term on the Executive Counsel as Vice President of ASAM. He begins a two-year term as Treasurer of ASAM in April 2023. Dr. Wiegand founded and led the Toxicology service at URMC until 2022 when he became Director of Addiction Medicine and Director of Addiction Medicine Consults also at URMC in the Department of Emergency Medicine. Dr. Wiegand has served as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and he is the Fellowship Director for the URMC Medical Toxicology fellowship expecting to formally begin once accredited, in July of 2023.
Alan D. Woolf, MD, MPH, FACMT, FAAP, FACCT
Associate Chief Medical Education Officer
Boston Children's Hospital
Dr. Alan D. Woolf is a pediatrician and medical toxicologist. He is the Associate Chief Medical Education Officer at Boston Children’s Hospital and a Professor of Pediatrics at Harvard Medical School. He is Medical Director of the Pediatric Environmental Health Center at Boston Children’s Hospital, Director of the Pediatric Environmental Health Fellowship Training Program, and Principal Investigator of the Region 1 New England Pediatric Environmental Health Specialty Unit. He is currently a member of the Executive Committee of the American Academy of Pediatrics’ Council on Environmental Health & Climate Change and a member of the PFAS Subcommittee of the National PEHSU Program. Dr. Woolf has served as a consultant regarding PFAS water contamination to both the New Hampshire and Massachusetts Departments of Public Health since 2014. He co-authored one of the first papers to describe the PFAS water contamination event in Portsmouth NH and was a ‘Community Liaison’ giving input to the NASEM Report on PFAS published in 2022. He is currently a member of the New Hampshire State Advisory Committee on PFAS and cancer.
Dr. Woolf is a past-president of both the American Academy of Clinical Toxicology and the American Association of Poison Control Centers. In 2018, Dr. Woolf received the Career Achievement Award from the AACT and, in 2019, he was named the Louis Roche Lecturer by the European Association of Poisons Centers and Clinical Toxicologists. He is the Editor of the recent book The History of Modern Clinical Toxicology published by Elsevier Publishers in 2021.
Nasim Zamani, MD
Fellowship of Clinical Toxicology
Shahid Beheshti University
Nasim Zamani graduated from Azad University of Medical Sciences in Tehran, Iran in 2004. She started residency in Forensic Medicine and Clinical Toxicology in 2008 and finished the course with the first rank of the national board followed by fellowship program in clinical toxicology in Loghman Hakim Hospital- one of the largest in-patient clinical toxicology centers in the world- in affiliation with Shahid Beheshti University of Medical Sciences. After graduation, She started to work in the same setting as attending physician in 2014 where she was responsible for patient treatment, teaching, and research in the field. She has won three international grants in the field of clinical toxicology and is currently a board member of APAMT and a member of EAPCCT.
Matthew Zuckerman, MD
University of Colorado School of Medicine
Dr. Matt Zuckerman is an medical toxicologist at the University of Colorado Anschutz Medical Campus and Rocky Mountain Poison & Drug Safety. He is the pharmacology content director for the CU School of Medicine curriculum.